September 2021

Contents

Editorial

• HTB: no. 9 – plus HIV and COVID-19 (17 September 2021)

Special reports

• Pipeline report 2021: HIV drugs in development

Conference reports

• 11th IAS Conference on HIV Science (IAS 2021)

• IAS 2021 website now open access

• Substudies from the ODYSSEY trial: results July 2021

• Trial design for next generation PrEP

Antiretrovirals

• Lenacapavir submitted to EMA for MDR HIV

Treatment access

• Darunavir/ritonavir price now US $210 for global access

Coinfections and complications

• HPV vaccine prevent penile infections in young gay men

HIV prevention and transmission

• Imbokodo trial results highlight challenge of developing an HIV vaccine and urgent need for access to proven prevention tools

• Moderna registers HIV vaccine study

Research studies

• START study: call for participants to attend final visit – please help…

COVID-19: HIV and COVID-19 coinfection

• New COVID-19 vaccine information from Modern ART for South Africa

• BHIVA statements on third vaccine doses for people living with HIV

• HIV increases risk of severe COVID-19 in largest US study

• SARS-CoV-2 variants and immunosuppression

COVID-19: vaccine research

• UK vaccine programme saved 100,000 lives

• Large US registry confirms safety of COVID-19 vaccines during pregnancy

• US FDA grants full approval to Pfizer vaccine

• Immune responses against Delta variant in people vaccinated in the UK

• Neutralising antibody levels from COVID vaccines correlate negatively with age

• Evolution of neutralising antibody responses to natural infection and after vaccination

COVID-19: transmission & prevention

• Outbreak of 469 symptomatic Delta cases in fully vaccinated adults during Bear Week

Job vacancies

• Job vacancies: Medical writer

PDFs

• HTB: no. 9 – plus HIV and COVID-19 (17 September 2021)